This Article Abstract Free Full Text (Free PDF) Free Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Dams, G. Articles by Hertogs, K. Search for Related Content PubMed PubMed Citation Articles by Dams, G. Articles by Hertogs, K. Social Bookmarking                         What's this?

A Time-Resolved Fluorescence Assay to Identify Small-Molecule Inhibitors of HIV-1 Fusion

Tibotec BVBA, Mechelen, Belgium

Koen Van Acker

Tibotec BVBA Gen De Wittelaan L 11B 3 2800 Mechelen, Belgium E-mail: kvacker{at}tibbe.jnj.com

Emmanuel Gustin

Tibotec BVBA, Mechelen, Belgium

Inge Vereycken

Tibotec BVBA, Mechelen, Belgium

Lieve Bunkens

Tibotec BVBA, Mechelen, Belgium

Pascale Holemans

Tibotec BVBA, Mechelen, Belgium

Liesbet Smeulders

Tibotec BVBA, Mechelen, Belgium

Reginald Clayton

Tibotec BVBA, Mechelen, Belgium

Asa Ohagen

Tibotec BVBA, Mechelen, Belgium

Kurt Hertogs

Tibotec BVBA, Mechelen, Belgium

Fusion of host cell and human immunodeficiency virus type 1 (HIV-1) membranes is mediated by the 2 "heptad-repeat" regions of the viral gp41 protein. The collapse of the C-terminal heptad-repeat regions into the hydrophobic grooves of a coiled-coil formed by the corresponding homotrimeric N-terminal heptad-repeat regions generates a stable 6-helix bundle. This brings viral and cell membranes together for membrane fusion, facilitating viral entry. The authors developed an assay based on soluble peptides derived from the gp41 N-terminal heptad-repeat region (IQN36) as well as from the C-terminal region (C34). Both peptides were labeled with fluorophores, IQN36 with allophycocyanin (APC) and C34 with the lanthanide europium (Eu3+). Formation of the 6-helix bundle brings both fluorophores in close proximity needed for Förster resonance energy transfer (FRET). Compounds that interfere with binding of C34-Eu with IQN36-APC suppress the FRET signal. The assay was validated with various peptides and small molecules, and quenching issues were addressed. Evaluation of a diversified compound collection in a high-throughput screening campaign enabled identification of small molecules with different chemical scaffolds that inhibit this crucial intermediate in the HIV-1 entry process. This study's observations substantiate the expediency of time-resolved FRET-based assays to identify small-molecule inhibitors of protein-protein interactions. (Journal of Biomolecular Screening 2007:865-874)

Key Words: HIV-1 • gp41 • fusion inhibitor • screening • Förster resonance energy transfer

References

• Gallo SA, Finnegan CM, Viard M., Raviv Y., Dimitrov A., Rawat SS, et al: The HIV Env-mediated fusion reaction. Biochim Biophys Acta 2003; 1614:36-50.[Medline] [Order article via Infotrieve]
• Eckert DM, Kim PS: Mechanisms of viral membrane fusion and its inhibition. Annu Rev Biochem 2001;70:777-810.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Wild CT, Shugars DC, Greenwell TK, McDanal CB, Matthews TJ: Peptides corresponding to a predictive alpha-helical domain of human immunodeficiency virus type 1 gp41 are potent inhibitors of virus infection. Proc Natl Acad Sci USA 1994;91:9770-9774.[Abstract/Free Full Text]
• Kilby JM, Hopkins S., Venetta TM, DiMassimo B., Cloud GA, Lee JY, et al: Potent suppression of HIV-1 replication in humans by T-20, a peptide inhibitor of gp41-mediated virus entry. Nat Med 1998;4:1302-1307.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Chan DC, Fass D., Berger JM, Kim PS: Core structure of gp41 from the HIV envelope glycoprotein. Cell 1997;89:263-273.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Chan DC, Chutkowski CT, Kim PS: Evidence that a prominent cavity in the coiled coil of HIV type 1 gp41 is an attractive drug target. Proc Natl Acad Sci USA 1998;95:15613-15617.[Abstract/Free Full Text]
• Lu M., Blacklow SC, Kim PS: A trimeric structural domain of the HIV-1 transmembrane glycoprotein. Nat Struct Biol 1995;2:1075-1082.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Root MJ, Steger HK: HIV-1 gp41 as a target for viral entry inhibition. Curr Pharm Des 2004;10:1805-1825.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Liu S., Jiang S.: High throughput screening and characterization of HIV-1 entry inhibitors targeting gp41: theories and techniques. Curr Pharm Des 2004;10:1827-1843.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Ryu J-R., Lee J., Choo S., Yoon SH, Woo E-R., Yu YG: Development of an in vitro assay system for screening of gp41 inhibitory compounds. Mol Cells 1998;8:717-723.[Web of Science][Medline] [Order article via Infotrieve]
• Jin B-S., Lee W-K., Ahn K., Lee MK, Yu YG: High-throughput screening method of inhibitors that block the interaction between 2 helical regions of HIV-1 gp41. J Biomol Screen 2005;10:13-19.[Abstract/Free Full Text]
• Mo H., Konstantinidis AK, Stewart KD, Dekhtyar T., Ng T., Swift K., et al: Conserved residues in the coiled-coil pocket of human immunodeficiency virus type 1 gp41 are essential for viral replication and interhelical interaction. Virology 2004;329:319-327.[Web of Science][Medline] [Order article via Infotrieve]
• Frey G., Rits-Volloch S., Zhang X-Q., Schooley RT, Chen B., Harrison SC: Small molecules that bind the inner core of gp41 and inhibit HIV envelope-mediated fusion. Proc Natl Acad Sci USA 2006;103:13938-13943.[Abstract/Free Full Text]
• Gochin M., Savage R., Hinckley S., Cai L.: A fluorescence assay for rapid detection of ligand binding affinity to HIV-1 gp41. Biol Chem 2006;387: 477-483.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Hemmilä I., Webb S.: Time-resolved fluorometry: an overview of the labels and core technologies for drug screening applications. Drug Discov Today 1997;2:373-381.[CrossRef][Web of Science]
• Selvin PR: Principles and biophysical applications of lanthanide-based probes. Annu Rev Biophys Biomol Struct 2002;31:275-302.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Eckert DM, Malashkevich VN, Kim PS: Crystal structure of GCN4-pIQI, a trimeric coiled coil with buried polar residues. J Mol Biol 1998; 284:859-865.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Lu M., Kim PS: A trimeric structural subdomain of the HIV-1 transmembrane glycoprotein. J Biomol Struct Dyn 1997;15:465-471.[Web of Science][Medline] [Order article via Infotrieve]
• Mathis G.: Rare earth cryptates and homogeneous fluoroimmunoassays with human sera. Clin Chem 1993;39:1953-1959.
• Lambert DM, Zhou J., Medinas R.: HIV-1 isolates from patients treated with T-20 are sensitive to the second generation fusion inhibitor T-1249. Paper presented at the Third International Workshop on Drug Resistance and Treatment Strategies, San Diego, June 23-26, 1999.
• Greenberg ML, Davison D., Jin L., Mosier S., Melby T., Sista P., et al: In vitro antiviral activity of T-1249 a second generation fusion inhibitor. Antivir Ther 2002;7:S10.[Web of Science]
• Liu S., Lu H., Niu J., Xu Y., Wu S., Jiang S.: Different from the HIV fusion inhibitor C34, the anti-HIV drug Fuzeon (T-20) inhibits HIV-1 entry by targeting multiple sites in gp41 and gp120. J Biol Chem 2005;280:11259-11273.[Abstract/Free Full Text]
• Wang S., York J., Shu W., Stoller MO, Nunberg JH, Lu M.: Interhelical interactions in the gp41 core: implications for activation of HIV-1 membrane fusion. Biochemistry 2002;41:7283-7292.[CrossRef][Medline] [Order article via Infotrieve]
• De Clercq E.: Emerging anti-HIV drugs. Expert Opin Emerg Drugs 2005; 10:241-274.
• Zhao X., Singh M., Malashkevich VN, Kim PS: Structural characterization of the human respiratory syncytial virus fusion protein core. Proc Natl Acad Sci USA 2000;97:14172-14177.[Abstract/Free Full Text]
• Inglese J., Auld DS, Jadhav A., Johnson RL, Simeonov A., Yasgar A., et al: Quantitative high-throughput screening: a titration-based approach that efficiently identifies biological activities in large chemical libraries. Proc Natl Acad Sci USA 2006;103:11473-11478.[Abstract/Free Full Text]

This version was published on September 1, 2007

Journal of Biomolecular Screening, Vol. 12, No. 6, 865-874 (2007)
DOI: 10.1177/1087057107304645


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This Article Abstract Free Full Text (Free PDF) Free Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Dams, G. Articles by Hertogs, K. Search for Related Content PubMed PubMed Citation Articles by Dams, G. Articles by Hertogs, K. Social Bookmarking                         What's this?